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The large surface antigen L of duck hepatitis B virus exhibits a mixed topology with the preS domains of the protein alternatively exposed to
the particles' interior or exterior. After separating virions from subviral particles (SVPs), we compared their L topologies and showed that both
particle types exhibit the same amount of L with the following differences: 1—preS of intact virions was enzymatically digested with
chymotrypsin, whereas in SVPs only half of preS was accessible, 2—phosphorylation of L at S118 was completely removed by phosphatase
treatment only in virions, 3—iodine-125 labeling disclosed a higher ratio of exposed preS to S domains in virions compared to SVPs. These data
point towards different surface architectures of virions and SVPs. Because the preS domain acts in binding to a cellular receptor of hepatocytes,
our findings implicate the exclusion of SVPs as competitors for the receptor binding and entry of virions.
© 2006 Elsevier Inc. All rights reserved.Keywords: Duck hepatitis B virus; Virions; Subviral particles; Chymotrypsin; Envelope architecture; preSIntroduction
The family of Hepadnaviridae with the human hepatitis B
virus (HBV) as the prototype member consists of small DNA-
containing enveloped viruses, which cause severe liver diseases
in humans, rodents and birds (Barker et al., 1975; Ganem, 1996;
Schultz et al., 2004). One characteristic feature of mammalian
hepadnaviruses is the presence of three envelope proteins called
large (L), middle (M), and small surface protein (S). All three
proteins share the same sequence at the carboxy terminus, while
M consists in addition to S of a region designated preS2 and L is
further extended by the preS1 domain at the amino-terminal
end. L and S exist as unglycosylated and single-glycosylated
forms, whereas M appears single–as well as double-glycosy-
lated (Bruss and Ganem, 1991; Eble et al., 1986). In contrast,
the envelope of duck HBV (DHBV) contains only the two
unglycosylated surface proteins S (P18) and L (P36), where
consequently the S part of the latter is extended by a preS
subunit. A fraction of DHBV L is phosphorylated at several⁎ Corresponding author. Fax: +49 40 48051 117.
E-mail address: mbruns@hpi.uni-hamburg.de (M. Bruns).
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doi:10.1016/j.virol.2006.09.006serine and threonine residues, the major phosphorylation site
residing at amino acid position 118, S118 (Grgacic and
Anderson, 1994; Grgacic et al., 1998). Although both members
of hepatitis B viruses act similarly by producing a large amount
of so-called SVPs, which contain no nucleocapsid, those empty
particles show different features concerning their envelopes
(Ganem, 1991; Marion, 1988; Mason et al., 1980). Where SVPs
of HBV contain in contrast to HBV virions only very small
amounts of L, if at all (Heermann et al., 1984), the amounts of
envelope proteins of DHBV virions and SVPs disclose no
differences (Bruns et al., 1998). This may be one explanation
for the difficulties in separation of both DHBV particles by
density gradient ultracentrifugation, which so far is only
possible by using special separation techniques.
The importance of L for the infection process became
evident by the identification of DHBV neutralizing epitopes in
the preS region of L (Chassot et al., 1993; Chassot et al., 1994;
Lambert et al., 1991) and the demonstration that the host-range
specificity is also located on this part of the protein (Ishikawa
and Ganem, 1995).
On the other side, it is remarkable that an about 1000-
fold surplus of DHBV SVPs compared to virions usually
127C. Franke et al. / Virology 359 (2007) 126–136detected in sera of infected hosts, fails to inhibit the
infection process significantly, when the epitope composition
of the envelope is expected to be comparable. Moreover,
reduction of viral entry into the cell could only be
accomplished by using an extremely high dose of SVPs
(Bruns et al., 1998; Klingmuller and Schaller, 1993). On the
contrary, addition of recombinant L protein during infection
abolishes viral entry (Breiner et al., 1998). In the attempt to
interpret these data, the question came up whether virions
and SVPs attach to the same cellular receptor molecules
during the early phase of infection or whether they enter
hepatocytes using different pathways. In the latter case, one
would expect distinguishing envelope features. In order to
investigate the external envelope architecture, virions and
SVPs of DHBV were separated from each other by a special
separation technique using Urografin as a medium for steep
and flat gradients (Bruns et al., 1998). Thereupon, the
envelope proteins S (P18) and L (P36) of DHBV virions
and SVPs could be separately analyzed.Fig. 1. Separation of DNA-containing particles (virions) and SVPs of DHBV by two
with an anti-DHBVpreS antibody (top) and Southern blot with a labeled DHBV-DN
SVPs and virions separated by an Urografin gradient of 0 to 40%. Virions were main
present in fractions 8 and 9 as shown for the positions of viral DNA (bottom) or L p
SVPs (fractions 8 and 9) from the first steep gradient were collected and run in two pa
virions mainly in fractions 2 and 3 as revealed by Southern blot (bottom), whereas the
14 and 15 in theWestern blot (top). RC DNA, relaxed circular DNA; P36 and P28, the
SVP preparations because of its 1000-fold surplus over virions; M, digested pMaD-Results
Separation of DHBV particles into virions and SVPs
Virus particles, concentrated via ultracentrifugation were
separated into virions and SVPs over two alternative Urografin
gradient centrifugations, where the concentrated particles were
first placed on top of a 0 to 40% linear Urografin gradient and
centrifuged to equilibrium with 150,000×g for 18 h (Fig. 1a).
Thereafter, fractions of the gradients positive for viral DNA (as
an attribute of virions) and fractions negative for viral DNA but
positive for L protein (predominantly detected in association
with the much higher number of SVPs) were collected
independently and subsequently subjected to two parallel
isopycnic centrifugations in 26.5% Urografin at 150,000×g for
18 h for further enrichment and separation of virions and SVPs
(Fig. 1b). Fractions of the latter gradients were again analyzed
for viral DNA and L demonstrating the efficiency of separation
between DNA-containing virions concentrated near the bottomsuccessive ultracentrifugations in different Urografin gradients. (a) Western blot
A probe (bottom) were performed on ultracentrifugation fractions to distinguish
ly concentrated at higher densities in fractions 6 and 7, whereas most SVPs were
rotein (preS, top), respectively. (b) Partly purified virions (fractions 6 and 7) or
rallel flat gradients of 26.5% Urografin. The gradient shown on the left enriched
second gradient on the right demonstrated the accumulation of SVPs in fractions
large surface protein (L) and the cleavage product of it, most prominently seen in
26 plasmid DNA.
Fig. 2. Examination of the envelope proteins of DNA-containing DHBV
particles and particles devoid of DNA. 1010 virions (V) and SVPs (S) each were
four times side by side in parallel electrophoretically separated. After blotting
the membrane, sections were cut and incubated with anti-C, anti-S, anti-preS and
anti-HSC70 antibodies. No crucial differences could be demonstrated in the
amount of envelope proteins between virion and SVP fractions. The large
surface protein L (P36) and its cleavage product (P28) were detected with an
antibody recognizing the preS part of this component only, whereas the small
surface protein S (P18) was demonstrated with an antibody reacting with the S
subunit present in both envelope proteins. Additionally, the cellular heat shock
protein HSC70 was found to be present in similar amounts in the virion as well
as SVP fractions. The viral core protein P32 (C) was only present in the
nucleocapsid-containing virions. The two upper bands, detected with anti-C, are
contaminating proteins of unknown origin.
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less densities remained at the top of the second Urografin
gradient run in parallel (Fig. 1b, right). Table 1 gives a typical
example of the enrichment for virions and SVPs by the two-
step gradient ultracentrifugation. The virion fraction was 10-
fold enriched for virions and at the same time the amount of
SVPs in that fraction was approximately reduced by a factor
of 10. So, the overall composition of that fraction was about
100-fold enriched for virions when compared to the virion–
SVP-ratio in the mixture (although it should be noted that in
this sample the accuracy of the measurement of the amount of
L/μl as an evaluation for SVPs was rather low because the
signal was close to background level). The SVP fraction was
more than 30-fold enriched for SVPs and the amount of
virions in that fraction was reduced about 120-fold at the same
time. So, the overall composition of this fraction was nearly
4000-fold enriched for SVPs when compared to the starting
mixture.
Virions and SVPs of DHBV contain the same proteins and in
similar amounts within the viral envelopes
In general, no different composition of the viral envelope
proteins was evident within purified virions and SVPs. The
following experiment (Fig. 2) exhibited the similar composition
of the envelopes of both entities. When 1×1010 virions were
compared with 1×1010 SVPs, only minor quantity differences
could be seen in Western blots of electrophoretically separated
DHBVenvelope proteins. This was also true for the cellular heat
shock protein HSC70, whose presence in DHBV particle
preparations (unpublished observation) and role in the activa-
tion of the viral reverse transcriptase (Beck and Nassal, 2003)
were demonstrated earlier.
Proteolytic cleavage products of viral envelope proteins
SVPs were now selected for the analysis of the proteolytic
cleavage products after the digestion of intact particles with
chymotrypsin. Enzymatically treated and untreated SVPs were
separated by PAGE to be investigated in subsequent Western
blots with different monoclonal and polyclonal antibodies (Fig.
3, bottom). The polyclonal antisera were introduced in this
experiment as controls because of their ability to detect allTable 1
Enrichment of DHBVand SVPs as monitored by measuring the amount of viral
genome equivalents (vge) a and L protein molecules b
Virus sample vge/ml L/ml
Mixture (start) 3.7×108 3.8×1011
Purified virions 3.9×109 c 4.1×1010
Purified SVPs <3.1×106 1.2×1013 d
a Calculated by dot blot experiments using a radioactively labeled DHBV-
DNA probe.
b Calculated in a BioRad Fluor-S™Multi Imager with the program “Quantity
One” and an anti-preS antiserum.
c Corresponding to 12.72 pg/μl.
d Corresponding to 47.78 ng/μl.possible fragmented products in addition to the intact S and L
proteins (Figs. 3d and e). The proteolytic cleavage products
detected by the epitope-specific monoclonal antibodies (Mabs)
900, 1D2, and 7C.12 (Chassot et al., 1993; Guo and Pugh,
1997a; Lambert et al., 1990) or by polyclonal anti-S or anti-preS
antibodies are depicted in the upper segment of Fig. 3. Their
variety suggests that the digest was either incomplete or the
conformation of envelope proteins within the membrane of
intact particles differed in a way that chymotrypsin recognition
sites were alternatively accessible or hidden from enzymatic
attack, because different cleavage products of P28 (16 kDa and
17 kDa) and P36 (21 kDa and 26 kDa) were observed. At the
domain structure of L, all possible chymotrypsin recognition
sites are marked with the exception of a section between the two
trans-membranous regions TM1 and TM2 (Eble et al., 1986).
This area, which is situated near the amino-terminal end of P18
as well as of the corresponding S subunit of P36, should be
protected against a direct interaction with any enzyme because
of its internal localization. Mabs 900 and ID2 detected a
chymotrypsin cleavage fragment with a relative molecular
weight of 18 kDa (Figs. 3a and b). This fragment is obviously
part of the preS domain of L as Mabs 900 and ID2 recognize
only epitopes within that subunit. Mab 7C.12 instead as the anti-
S antiserum detects a cleavage fragment of similar size (17 kDa)
but as this antibody recognizes an epitope within the S domain
of P36 these two chymotrypsin cleavage products must be of
different origin (Figs. 3c and d).
Another fragment with a relative molecular weight of 21 kDa
could be detected with all other antibodies (Figs. 3b–e), but not
with Mab 900 (Fig. 3a). The appearance of such a fragment can
be most plausibly explained, when parts of the amino-terminus
as well as of the carboxy-terminus of L were removed by
Fig. 3. Chymotrypsin recognition sites and the identification of the potential chymotrypsin-induced preS and S protein fragments by different antibodies. Purified
SVPs were divided to be incubated with chymotrypsin (+) or not (−). After enzyme treatment, viral proteins were disrupted, separated by PAGE in five parallel pairs of
chymotrypsin-treated and mock-treated samples (a–e) and blotted onto a membrane. For Western blots, the membrane was cut and either incubated with the Mabs 900
(a) or 1D2 (b) for the identification of epitopes on the preS region, or with Mab 7C.12 (c) for the recognition of an epitope within S. In addition, the polyclonal anti-S
and anti-preS antisera were used recognizing epitopes across the entire S and preS domains respectively. The upper part presents graphically the domain structure of L
(open bar), where the dotted areas mark the epitopes detected by the different Mabs and the striped boxes the two known transmembraneous regions (TM1 and TM2)
enclosing a region most probably protected against enzymatic attacks. The fat arrows on top designate the starting points for translation of P36 and P18, respectively,
and the identical termination point for both proteins, whereas the small arrows below L illustrate the possible recognition sites for chymotrypsin with the exception of
the protected region between TM1 and TM2. The small numbers above and below elucidate different amino acid positions. The bars below L illustrate the original viral
proteins (strong bars) and their possible cleavage products (thin bars) as detected by the different antibodies. The naturally occurring cleavage product of L, P28, as
visible in blots with untreated SVPs (c, d and e), is not introduced in the diagram.
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clarity not shown) or aa 122 and 303 intact (see the 21 kDa
fragment drawn in the sketch on top of Fig. 3). If this is true and
the conformation allows access, S should also be processed at aa
297 and/or 303 to give rise to fragments of 16 and/or 17 kDa. In
this respect, it was not surprising to detect with Mab 7C.12
besides the original P18 some cleavage products with relative
molecular weights of 16 kDa and 17 kDa (Fig. 3c), obviously
representing carboxy-terminally truncated polypeptides origi-
nating from P18. On the other side, there was the unexpected
observation that more than half of L remained intact and could
not be manipulated enzymatically (Figs. 3 a, b and e). If this was
not because of an incomplete digest, this finding supports data
that showed that the preS domains of L were partly hiddeninside the envelope and partly located on the outside of the viral
particles (Grgacic and Anderson, 1994; Guo and Pugh, 1997b).
Figs. 3c and d also show that P28, a cleavage product of L
(Fernholz et al., 1993), always detectable in infected primary
duck hepatocytes (PDHs) and in purified virus (Bruns et al.,
1998), also remained at least partially unaffected by the enzyme.
This product, which is for reason of clarity not inserted in the
map, can be detected by both polyclonal antisera (Figs. 3d and
e) as well as all three Mabs, which maps the protein to include
aa 83 to 276 of L. Comparing the Mab reaction in parallel it was
evident that only Mab 7C.12 was able to strongly detect P28
(Fig. 3c). At the same time, the detection of the full length P28
after chymotrypsin digestion suggests a localization that
protects it from enzymatic attack.
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the outside
Using the anti-DHBVpreS antiserum, which strictly
recognizes the amino-terminal end of L, we wanted to
investigate differences in the exposure of preS domains of
virions and SVPs. Purified intact particles from DHBV
positive duck serum were separately digested with chymo-
trypsin or mock digested. After the digest particles were
subjected to ultracentrifugation in a 0–70% sucrose gradient to
dispose of detached peptides. Fractions were drawn and
assayed for the preS domain in protein dot blotting and
Western blotting (Fig. 4). Virions and SVPs behaved strikingly
different in this assay. As was to be expected, after digestion
with chymotrypsin, almost no L protein could be detected
either on the surface of virions or SVPs, when judged against
virus particles treated with buffer only (Figs. 4a and b, top).
This result argues for a complete removal of surface preS
domains by digestion at aa position 167 (compare Fig. 3). The
Western blots of virions stripped off the external preS domains
showed surprisingly that essentially no P36 was left, whereasFig. 4. Differential exposure of preS domains on the exterior of virions and SVPs. Pu
containing chymotrypsin (right). After the digest particles were subjected to separati
fractions were directly dotted onto membranes (upper strips), whereas the remaining
blots). Then, strips and blots were treated with the anti-preS antibody for the detection
of buffer-treated (left) as well as fraction 11 of chymotrypsin-treated virions (right)
relative molecular weights of 17, 21, and 26 kDa are cleavage products of L detectecleavage products of 26, 21 and 17 kDa could be detected
(Fig. 4a, bottom right). Unlike virions, Western blotting of
chymotrypsin digested SVPs revealed significant amounts of
intact P36, which must have been buried within the membrane
or particle. Besides P36, minor amounts of 26 kDa and 21 kDa
cleavage products were evident (Fig. 4b, bottom right). Taken
together, the most important finding after treatment of intact
purified viral particles with chymotrypsin was the general loss
of the preS domain of P36 in virions, whereas more than 50%
of this subunit in SVPs remained not involved in the cleavage.
This result gives good evidence to argue for a general
difference in the topology of envelope proteins of virions and
SVPs with almost all of the preS domains exposed on the
virion exterior but more than half of them buried within the
interior of SVPs.
The phosphorylated preS domain is completely exposed on the
exterior of virions but partially hidden in SVPs
The preS domain of L bears a major phosphorylation site
at aa 118 (S118), whose phosphorylation is responsible for arified virions (a) or SVPs (b) were either incubated in buffer (left) or in solution
on in a 0 to 70% sucrose gradient. One-microliter aliquots of particle-containing
fractions were subjected to PAGE and thereafter blotted onto membranes (lower
of the amino-terminal region of P36. The asterisks above the strips at fraction 10
single out the DNA peaks measured in parallel (not shown). The products with
d with the anti-preS antibodies.
Fig. 5. Comparison of the phosphorylated surface proteins of virions and SVPs
from DHBV. Purified virions or SVPs were either left untreated (1 and 3) or were
treated with acid phosphatase (2 and 4) to remove the phosphates from the
outside accessible phosphorylation of L. Enzymatically digested particles were
subjected to PAGE and Western blotting with the anti-preS antibody. The
phosphorylated form of L (PP36) runs slightly above P36. Treatment of virions
with phosphatase removed PP36; a partial dephosphorylation of P28 is also
visible (not indicated, compare the corresponding regions in lanes 1 and 2). By
contrast, SVPs treated with phosphatase preserved PP36.
Fig. 6. Analysis of the surface components of virions and SVPs accessible for iodinati
S; the tyrosines in the center of the S domain (grey arrows) are most probably protecte
fractions after gradient purification (left). Fractions 6 and 7 of the virion gradient were
were again subjected to PAGE. The gels were dried and exposed to X-ray film (right).
9 were combined and particle surfaces labeled with radioactive iodine. Labeled particl
(right). The strongly labeled component/s shown on top of both gels could represe
particles or co-purified serum albumin (Alb) eventually adhered to the outside of the
(P18) are shown on the right side together with the ratios of measured radioactiv
representing L and the dried gel containing the iodinated proteins of the virions (a)
comparison with the corresponding samples of SVPs (b). DL and DS, DHBV mark
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to a position of 37 kDa. PP36 is thus easily distinguishable
from P36 in Western blotting (Grgacic et al., 1998). PP36 of
serum derived viral particles has been shown to be resistant to
phosphatase digestion in the absence of detergents (Grgacic
and Anderson, 1994). Considering the large excess of SVPs
over virions in serum, this has to hold true for SVPs; it,
however, may be different for virions. If almost all of the
preS domains of virions are actually exposed on the outside
of the particle, it would be expected that phosphatase
treatment of intact virions is able to remove phosphorylation
at S118 together with the aberrant migration band PP36.
We compared purified untreated virions and SVPs (Fig. 5,
lanes 1 and 3) with phosphatase-treated virions and SVPs in
Western blots (Fig. 5, lanes 2 and 4) and could show that PP36
of virions was almost completely lost during the phosphatase
treatment (Fig. 5, lane 2), whereas PP36 of SVPs remained
visible (Fig. 5, lanes 3 and 4). This result adds to the evidence
for a different topology of L in virions and SVPs.on. (a) Position of tyrosines, Tyr (arrows), as the target for iodine in DHBV L and
d against iodination because of their inner localization. (b) Western blot of virion
combined and particle surfaces labeled with radioactive iodine. Labeled particles
(c) Western blot of SVP fractions after gradient purification (left). Fractions 8 and
es were again subjected to PAGE. The gels were dried and exposed to X-ray film
nt the cellular heat shock protein (HSC70) generally co-purified with DHBV
particles. The positions of the DHBVenvelope proteins L (P36 and P28) and S
ity demonstrating the degree of their external localizations. The Western blot
were exposed exactly tenfold longer to get an adequate darkening of bands for
er proteins from DHBV positive duck liver and serum, respectively.
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tyrosines on preS and S domains of virions and SVPs
The sequence of L harbors 7 tyrosines (Y), Y10, Y138,
Y179, Y258, Y274, Y293 and Y363, that can theoretically be
labeled with radioactive iodine (Fig. 6). Y10, Y138 and Y179
are positioned on the preS domain; Y258, Y274 and Y293 are
found within the sequence between TM1 and TM2. Because
this region is believed to have an internal orientation, these
three sites should not be accessible for iodination without prior
disruption of the particles. Finally Y363 is located close to the
C-terminal end of the S domain. Radioactive labeling of all
four theoretically from the outside accessible tyrosines should
result in an L-to-S-signal ratio of 4:1. This holds true for
particles where the preS domain is exclusively located on the
outside. Internal localization of preS domains should conse-
quently shift this ratio towards a lower L-signal. For the
following iodination experiment, virions and SVPs, each
enriched by steep and flat Urografin gradients, were again re-
purified over a 0–40% Urografin gradient to obtain highly
purified intact viral particles for their external labeling. A
preliminary investigation of aliquots of the fractions by Western
blots revealed the grade of purity for both particles, where in the
virion-containing fractions no SVPs at a density of 1.14 g/cm3
could be detected, but only particles migrating to the expected
position of 1.17 g/cm3 and vice versa (Figs. 6b and c, left). The
virion gradient fractions 6 and 7 with an average density of
1.17 g/cm3 (Fig. 6b, left) and the SVP gradient fractions 8 and 9Fig. 7. Model for the topology of the large envelope proteins of DHBV virions and SV
loop from L in virions, whereas most of the amino-terminal part of this compone
nucleocapsid in virions might deliver an explanation for the improbability of an inter
preS domains to be positioned within the viral membrane.with an average density of 1.14 g/cm3 (Fig. 6c, left) were
collected, concentrated by ultracentrifugation, and the pellets
were resolubilized in phosphate buffer before iodination with
the IODO-GEN procedure, which, as verified for another
enveloped virus (Bruns et al., 1983; Bruns et al., 1986),
exclusively labeled the viral outside. After the labeling
procedure, viral particles were disrupted and separated by
PAGE to reveal the amount and identity of labeled proteins of
virions (125I-virions; Fig. 6b, right) and SVPs (125I-SVPs; Fig.
6c, right). The analysis of the radioactive signals of both
particles revealed a similar pattern of proteins. According to
their co-migration with DHBV envelope proteins detected by
Western blot, radioactively labeled components could be
identified as L (P36 and P28) and S (P18). Another dominantly
labeled band consisting of at least one protein at a position of
about 70 kDa could originate from co-purified and labeled
HSC70 protein, whose presence in purified DHBV particle
preparations was demonstrated in an earlier experiment (see
Fig. 2). As the exact localization of HSC70 is not known, we
can only speculate how far the radioactive iodine molecules
were able to penetrate the membrane to come into close contact
with this component, but obviously not so far as to label the core
protein. Alternatively, the secretion of HSC70 as part of the
membrane of exosomes has been described (Broquet et al.,
2003; Tytell, 2005). Preliminary experiments in our laboratory
have shown that HSC70 originating from the supernatants of the
chicken hepatoma cell line LMH (Kawaguchi et al., 1987) runs
in the same fractions of Urografin gradients as DHBV virionsPs. (a) Complete accessibility of chymotrypsin leads to the removal of the preS
nt is protected against the enzymatic attack in SVPs. (b) The presence of the
nal localization of L in virions (left), whereas the absence of this obstacle allows
133C. Franke et al. / Virology 359 (2007) 126–136and SVPs. Thus, copurified exosomes carrying HSC70 in their
membrane could be responsible for the iodinated 70 kDa
species. Additionally, serum albumin secreted from PDHs and
eventually sticking to the surface of the particles could account
for this band. Although not precisely known for ducks, both
HSC70 and albumin carry several tyrosines as candidates for
iodination. HSC70 is an extremely well conserved protein
exhibiting 15 tyrosines; human albumin carries 19 and that of
chicken, 20 tyrosines.
Virion protein bands were excised and their amount of
radioactivity measured. Comparison of signal intensities
resulted for virions in an L-to-S-ratio of 4:1 and for SVPs in
an L-to-S-ratio of 0.5:1. The L-to-S-ratio of radioactively
iodinated virions nicely reflects the expected ratio, when all of
the preS domains are exposed on the virion surface (see above,
Figs. 6 and 7). The low L-to-S-ratio of labeled SVPs points
towards a general difference in the topology of preS domains of
SVPs compared to virions. The fact that the radioactive signal
for L was lower than that for S could indicate that almost all
preS domains including some of the L C-termini are buried
within the particle and not accessible for iodination. We take
this as additional proof for the different surface architectures of
DHBV virions and SVPs.
Discussion
The relatively successful separation performance using
gradient ultracentrifugation for HBV particles facilitated the
discovery that the surfaces of HBV virions and SVPs differ
strongly in as far as L is missing in the latter (Ganem, 1991;
Marion, 1988; Mason et al., 1980). Meanwhile, potential
differences in the surface architecture of DHBV virions and
SVPs with both particles exhibiting the same L-to-S-ratio
remained enigmatic because of the difficulty to separate them.
For this reason, mixed DHBV particle preparations were used
up to now for studies of the viral envelope, which can, because
of the large excess of SVPs over virions, more or less be
interpreted as SVP-preparations (Grgacic and Anderson, 1994;
Grgacic and Anderson, 2005; Grgacic and Schaller, 2000). We
employed here a special multiple step ultracentrifugation
protocol using subsequent steep and flat Urografin gradients,
which made the separation of both particle types for an
examination of the viral surface proteins possible (Bruns et al.,
1998). Although on the first view infectious and non-infectious
particles revealed no diversity in the composition of their
envelope components, the absolute amounts of S and L, we
were able to accumulate evidence for a different orientation of
preS domains on the surfaces of virions and SVPs with almost
all of them exposed on the virion exterior but the majority of
them buried within the SVP. First, we showed that almost all
preS domains of virions exposed to chymotrypsin were
digested, whereas a large amount of the respective domains of
SVPs remained intact. Secondly, we could illustrate that the
phosphorylation of L at S118 could be removed by incubating
intact virions with phosphatase, while SVPs remained phos-
phorylated. And finally, specific labeling of tyrosines on the
outside of undisrupted particles with iodine-125 disclosed asignificantly higher ratio of exposed preS domains to S domains
in virions compared to SVPs. Considering the usual high
surplus of SVPs over virions, the observed discrepancies
between the published data and our findings were not generally
surprising.
As a summary of our results, we extend a model first
presented by Guo and Pugh (1997b): our data clearly
demonstrate that most, if not all, preS domains in virions are
located on their surface, whereas the majority of them in SVPs
are hidden inside (Fig. 7a). Treatment of virions with
chymotrypsin leads to a nearly total removal of all preS
domains of the particles, while incubation of SVPs with that
protease leaves most of L unaffected. When the different
topology of L was first discovered by Guo and Pugh (1997b),
it was suggested that the preS loop of L will be translocated
during particle morphogenesis in a manor of spring-loaded
mechanism to their surface. According to our results, the initial
trigger for this mechanism could be mechanical or electrostatic
forces due to the envelopment of the nucleocapsid, leaving
only a very limited space between nucleocapsid and envelope
(Fig. 7b, left). On the contrary, the missing nucleocapsid in
SVPs might deliver a plausible explanation for the likely
localization of preS domains inside the empty particles (Fig.
7b, right). In summary, these findings let us conclude that,
although the total quantities of surface proteins are nearly
identical in infectious and non-infectious particles, the surface
architectures of both particles are markedly different; where in
virions the majority of preS-loops is localized on the outside,
they are much less numerously exposed on the surface of
SVPs. In this respect, DHBV SVPs resemble the surface of
HBV SVPs, where L is not present at all. In addition, this point
of view combined with the knowledge that the attachment of
DHBV virions to host cells is accomplished by the contact of
the preS domain with the cellular receptor gp180/carboxypep-
tidase D (Breiner et al., 1998; Ishikawa et al., 1994; Kuroki et
al., 1994; Kuroki et al., 1995; Li et al., 1996; Tong et al., 1995,
1999; Urban et al., 1998), could provide an explanation why
the usual large surplus of SVPs in DHBV does not inhibit
infectivity (Bruns et al., 1998; Klingmuller and Schaller,
1993).
Finally, since gp180 is not exclusively expressed on
hepatocytes, it remains to speculate whether the viral envelope
architecture bears the necessary information for the penetration
of the hepatocyte membrane. A multi-receptor complex as
proposed by Li et al. (2004) could possibly discriminate
between a higher and lower amount of exposed preS domains.
Otherwise, when viral entry does not distinguish between
virions and SVPs, as imposed by equal binding of both particle
types on the hepatocellular membrane (Funk et al., 2004), one
could imagine a mechanism later in the process of infection. As
for viral entry, it has been shown that it proceeds by endocytosis
(Funk et al., 2004) followed by viral escape from late
endosomes after exposure of a translocation motif (TLM)
probably by proteolytic cleavage (Stoeckl et al., 2006).
Competition of SVPs for the protease activity and thus
inhibition of efficient virus cleavage could be counteracted by
the internal localization of preS domains.
134 C. Franke et al. / Virology 359 (2007) 126–136So far it remains unresolved whether virions and SVPs of
DHBV attach to the same receptor molecules or whether they
follow different pathways, maybe not only in liver parenchymal
but also in non-parenchymal cells like fat-storing (Ito) cells or
liver-specific macrophages (Kupffer cells) and liver-sinusoidal
endothelial cells (LSECs) (Breiner et al., 2001).
Materials and methods
Plasmid and antibodies
DHBV pMaD-26 plasmid DNA (Fernholz et al., 1993) was
alternatively cleaved with the restriction enzymes EcoRI and
HindIII and mixed in a ratio of 1:2 to obtain fragments of
3024, 1713, 1079 and 244 base pairs (bp). The Mabs 900 and
ID2 detecting epitopes within preS of the L protein between aa
83–90 and aa 127–138, respectively (Chassot et al., 1993), the
Mab 7C.12 identifying an epitope within the S domain between
aa 267 and 276 (Pugh et al., 1995), the polyclonal anti-S
(Klingmuller and Schaller, 1993), the anti-preS or the anti-C
antisera (Lambert et al., 1990; Schneider and Will, 1991) were
alternatively used for fragment analysis of the DHBV surface
proteins or the examination of intact DHBV particles.
Antibodies against HSC70 were obtained from Sigma (Deisen-
hofen, Germany).
Purification of virus
Virus purification was performed exactly as described
earlier (Bruns et al., 1998). In brief, virus particles were
isolated from sera of DHBV carrier ducks, which were infected
with strain DHBV-3 2 days after birth. Virus-containing
material was clarified by low-speed centrifugation and
thereafter layered onto 20% sucrose cushions in GNTE buffer
(0.2 M glycine, 0.2 M NaCl, 0.02 M Tris and 0.002 M EDTA,
pH 7.5) and centrifuged for 1 h in a SW55 rotor (Beckman,
Munich, Germany) at 200,000×g. The pellets were dissolved
in GNTE buffer and placed on top of a 0 to 40% linear
Urografin (3,5-diacetamido-2,4,6-tri-iodobenzoic acid, Scher-
ing AG, Berlin, Germany) gradient and centrifuged to
equilibrium with 150,000×g for 18 h. Fractions of the
gradients were drawn from the bottom of the tubes and
analyzed for viral DNA (as a trait of virions) and viral large
envelope protein (L) content. To separate particles of different
densities, the fractions of the first centrifugation step enriched
for viral DNA or devoid of viral DNA but enriched for viral
proteins (a characteristic of SVPs) were collected indepen-
dently and were subsequently subjected to two parallel
isopycnic centrifugations in 26.5% Urografin at 150,000×g
for 18 h for further enrichment and separation of virions and
SVPs. Fractions of the second gradients were again analyzed
for viral DNA and L. Those positive for viral DNA or devoid
of viral DNA but positive for L were collected, diluted in
GNTE buffer, pelleted by ultracentrifugation at 200,000×g and
stored at −70 °C as purified virions or purified SVPs,
respectively. Alternatively, before iodination, particles were
once more run through a 0–40% Urografin gradient for furtherpurification. All gradient centrifugation steps were carried out
at 4 °C using a SW55 rotor (Beckman).
Calculation of the amount of virus particles
After blotting the intact particles onto nitrocellulose
membranes, the number of viral genome molecules as
measured by dot blot hybridization and quantified by using
standards of cloned DHBV DNA (Fernholz et al., 1993;
Lambert et al., 1990) was considered equivalent to the number
of virions since viremic sera seem to contain very few defective
genomes (Jilbert et al., 1996). The amount of SVPs was
estimated by comparison of the L content of purified SVPs
with that of a defined number of virions in polyacrylamide gel
electrophoresis (PAGE) followed by immunoblotting with an
anti-DHBVpreS antiserum. The same signal intensity for
virions and SVPs after the immune reaction with anti-
DHBVpreS, measured in a BioRad Fluor-S™ MultiImager
with the program “Quantity One”, was taken as evidence for
roughly identical numbers because the two types of viral
particles are similar in size and seem to contain the same ratio
of L to S proteins (Bruns et al., 1998).
Enzyme treatment of purified viral particles
Separated purified DHBV particles were treated with 100
μg/ml chymotrypsin in phosphate-buffered saline (PBS), pH
7.5, for 0.5 h at room temperature as described earlier for
purified lymphocytic choriomeningitis (LCM) virus (Bruns and
Lehmann-Grube, 1984). In order to remove degraded products,
digested virus particles were ultracentrifuged in a 0 to 70%
sucrose gradient with 200,000×g for 4 h at 4 °C in a SW55
rotor (Beckman). For dephosphorylation, purified chymotryp-
sin-treated or mock-treated viral particles were, after removal
of degraded products, alternatively incubated with 1 U/ml acid
phosphatase or buffer only according to a protocol already
described (Grgacic and Anderson, 1994). All enzymes were
purchased from Sigma.
Preparation and analysis of DHBV DNA
Fractions of gradient centrifugations were diluted 5-fold
and viral particles were pelleted by ultracentrifugations.
Pellets were lysed with 1% NP40 and 0.5% sodium dodecyl
sulfate (SDS; Sigma) in 50 mM Tris–HCl (pH 8.0) containing
in addition 1 mM EDTA and 100 mM NaCl, and digested
with 500 μg/ml proteinase K overnight at 37 °C. Viral DNA
was extracted with phenol/chloroform and precipitated with
ethanol. The DNA was dissolved in TE buffer and subjected
to 1% horizontal agarose gel electrophoresis, followed by
transfer onto Hybond N membrane (Amersham Buchler,
Braunschweig, Germany) and UV cross-linking. For detection
of virions, DHBV-3 plasmid DNA was labeled with [γ-32P]
dCTP (Megaprime, Amersham Buchler) and used for
hybridization at about 106 CPM/ml. The same hybridization
protocol was applied to DNA dot blots, where a serial
dilution of DHBV-3 containing plasmid DNA was used as a
135C. Franke et al. / Virology 359 (2007) 126–136mass standard. Specifically bound radioactivity was quantified
using a Fuji Bas 2000 Phosphor Imager (Raytest, Essen,
Germany).
Detection of DHBV envelope proteins
Purified virions as well as SVPs were dissolved by boiling in
a double concentrated disruption buffer containing 4% SDS and
10% 2-mercaptoethanol and proteins were separated by PAGE
essentially according to the method published by Laemmli
(1970) in 5 to 20% gradient slab gels. For Western blot analysis,
proteins separated by electrophoresis were transferred to PVDF
membranes (BioRad Laboratories, Hercules, USA) and viral
antigens were detected by different rabbit anti-viral antisera or
by Mabs directed against epitopes within S and preS of the viral
envelope proteins followed by peroxidase-conjugated goat anti-
rabbit or anti-mouse sera (Dianova, Hamburg, Germany). The
bands were visualized by the ECL procedure according to the
manufacturer's protocol (Pierce, Rockford, USA). For labeling
of the surfaces of intact particles, iodination was performed
according to the IODO-GEN (Pierce, Rockford, U.S.A.)
procedure (Fraker and Speck, 1978) in 0.2 M phosphate buffer,
pH 7.5, a method formerly intensively studied with the external
iodination of purified lymphoytic choriomeningitis virus (Bruns
et al., 1983, 1986). In brief, aliquots of 200 μg IODO-GEN,
dissolved in 20 μl chloroform, were adsorbed by air-drying to
the bottom of 12×75 mm glass tubes. To such prepared glass
vessels, purified DHBV virions or SVPs in 90 μl of 0.2 M
phosphate buffer (pH 7.5) and 500 μCi/μg of Na125I were
applied. After a reaction time of 1 min at room temperature
(Amersham Buchler, Braunschweig), the iodinated compounds
were removed and particles were separated from free radioactive
iodine by ultracentrifugation through sucrose gradients as
described above. Then, the virus-containing fractions were
collected, diluted 1:10 and precipitated with 10% trichloroacetic
acid followed by two washing steps with ice-cold ethanol.
Iodinated samples were detected by the exposure of vacuum-
dried gels to X-ray films at −70 °C, the signals being intensified
as described (Laskey and Mills, 1977). Bands corresponding in
size to P36 and P18 were excised and measured for their content
of radioactivity with a γ-ray scintillation counter (BF Gammas-
cint 5300, Berthold, Wildbad). In the figures of this publication,
naturally occurring viral proteins are presented in bold letters,
whereas enzymatically formed products are shown in italics.Acknowledgments
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